Publication details
Postoje českých psychiatrů k léčbě depotními antipsychotiky
| Title in English | Attitudes of czech psychiatrists toward depot antipsychotics |
|---|---|
| Authors | |
| Year of publication | 2014 |
| Type | Article in Periodical |
| Magazine / Source | Česká a slovenská psychiatrie |
| MU Faculty or unit | |
| Citation | |
| Web | http://www.cspsychiatr.cz/detail.php?stat=971 |
| Field | Psychiatry, sexuology |
| Keywords | schizophrenia; non-adherence depot antipsychotics; attitudes towards depot antipsychotics |
| Attached files | |
| Description | Čéšková E. Attitudes of Czech psychiatrists toward depot antipsychotics Objective: The physicians diagnose and choose the treatment therefore their attitudes towards the treatment options are very important. Methods: A questionnaire-based study was performed with the aim to assess the opinions on adherence and management of non-adherence including the treatment with depot antipsychotics. Results: Most frequently psychiatrists (70.9%) evaluate the adherence to the treatment by the help of communication with the patient or family members. Further, they use the clinical picture (29.1%) and patients examination (22.2%). More than half of respondents manage the non-adherence with prescribing depot antipsychotics. Further, psychoeducation, change of the treatment and communication with the patient and family members are frequently used. The respondents estimate that the non-adherence can be solved with depot antipsychotics in half of patients with problematic adherence to treatment (48%). They treat a half of their patients suffering from psychosis with depot antipsychotics (in average 51%); 33% with the first-generation and 18% with the second-generation depot antipsychotics. The greatest obstacle for the treatment with the first-generation depot antipsychtic is considered to be (45% of respondents) side effects, and for the treatment with the second-generation a high cost (60%). Most respondents (62%) mean that the best time for treatment initiation with depot antipsychotics is the period before discharge from hospitalization when the stabilization is achieved. The greatest advantages of depot antipsychotics include the control of the treatment (36.8%) and certainty that the drug has been administered (29.9%). Conclusion: For assessment of non-adherence Czech psychiatrists use the classic methods as communication and they do not mention plasma monitoring. To address non-adherence they use most frequently depot antiipsychtoics; a surprisingly high percentage of psychotic patients is treated with depots. The greatest obstacle for prescribing depot antipsychotics is the cost. This should be a challenge for health politics makers. |
| Related projects: |